Stock Financial Ratios and Split History
INVA / Innoviva, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.
|Market Cap ($M)||1,699.91|
|Enterprise Value ($M)||2,411.84|
|Book Value ($M)||-242.86|
|Book Value / Share||-2.03|
|Price / Book||-7.87|
|NCAV / Share||1.67|
|Price / NCAV||9.54|
|Income Statement (mra) ($M)|
|Balance Sheet (mrq) ($M)|
|Cash & Equivalents||0.00|
|Cash / Share||0.00|
|Weighted Average Number Of Diluted Shares Outstanding||119,866,000|
|Common Shares Outstanding||101,824,355|
|Preferred Stock Shares Outstanding||0|
|Weighted Average Number Of Shares Outstanding Basic||106,945,000|
|Altman Z Score||N/A|
|Beneish M Score||N/A|
|Cash Conversion Cycle||N/A|
|Management Effectiveness (mra)|
|Return on Invested Capital (ROIC)||0.41|
|Return on Assets (ROA)||0.35|
|Return on Equity (ROE)||-0.38|
|Identifiers and Descriptors|
|Central Index Key (CIK)||1080014|
|SIC 2834 - Pharmaceutical Preparations|
Stock splits are used by Innoviva, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.
Peers - Pharmaceutical Preparations (2834)
ENDV / Endonovo Therapeutics, Inc.
AXIM / Axim Biotechnologies, Inc.
PRTT / Protect Pharmaceutical Corp
NNAB / NanoAntibiotics, Inc.
Related News Stories
The market was up 22% over the course of the past year, led by giants like Amazon.com, Inc. (NASDAQ:AMZN) and Facebook Inc (NASDAQ:FB), before the bottom finally fell out and investors’ fears for a correction materialized. (295-1)
Camtek Ltd. (CAMT - Free Report) is a metrology and inspection equipment, and software solutions provider. The Zacks Consensus Estimate for its current year earnings has been revised 10.2% downward over the last 30 days. (58-1)
Ladies and gentlemen, good afternoon. At this time, I'd like to welcome everyone to the Innoviva Fourth Quarter 2017 Financial Results Webcast and Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Today's conference call is being recorded. (31-0)
AstraZeneca Plc (AZN - Free Report) announced positive top-line results from a phase III study evaluating its investigational triple combination therapy PT010 for the treatment of chronic obstructive pulmonary disease (COPD). (164-0)
With the market up 22% up over the course of the past year, led by giants like Amazon.com, Inc. (NASDAQ:AMZN) and Facebook, Inc. (NASDAQ:FB), investors might fear that a pullback is just around the corner. And maybe one is. (295-9)